Chung-Ang University Hospital Reports Findings in Computers (Introduction of digital therapeutics)

2021 AUG 19 (NewsRx) -- By a News Reporter-Staff News Editor at Computer News Today -- New research on Computers is the subject of a report. According to news reporting originating in Seoul, South Korea, by NewsRx journalists, research stated, “Digital therapeutics are an emerging type of medical therapy and are defined as evidence-based therapeutic interventions for patients by means of qualified software programs to prevent, manage, or treat medical conditions. Today, digital therapeutics products are on the market or under development for a wide range of medical conditions such as diabetes, oncology treatment management, and neuropsychiatric disorders including anxiety disorder, depression, and substance use disorder.”

The news reporters obtained a quote from the research from Chung-Ang University Hospital, “Digital therapeutics can be more flexible than other treatment methods to address patients’ individual needs. The advantages of digital therapeutics fall in line with market demand; thus, the digital therapeutics market is expanding globally, focusing on advanced medical markets. There are many digital therapeutics products such as Sleepio for insomnia, Daylight for anxiety, Livongo and Omada products for diabetes, pre-diabetes, hypertension, etc. None of these are cleared by the Food and Drug Administration (FDA), but all are commercially available through health insurance or employers. The EU, including Germany, and a number of Asian countries, including Korea, Japan, and China, are also introducing policies for the regulation of new fields and digital therapeutics. The adoption of digital therapeutics is intricate and often involves various interests in numerous fields, decision-making processes, and individual or organizational value judgments.”

According to the news reporters, the research concluded: “For digital therapeutics to be thoroughly introduced into real life, technical aspects must be supported, and an approach that considers users must be further investigated.”

This research has been peer-reviewed.

For more information on this research see: Introduction of digital therapeutics. Computer Methods and Programs in Biomedicine, 2021;209:106319. Computer Methods and Programs in Biomedicine can be contacted at: Elsevier Ireland Ltd, Elsevier House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000, Ireland. (Elsevier - www.elsevier.com; Computer Methods and Programs in Biomedicine - http://www.journals.elsevier.com/computer-methods-and-programs-in-biomedicine/)

Our news correspondents report that additional information may be obtained by contacting Ji Sun Hong, Dept. of Psychiatry, Chung-Ang University Hospital, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, South Korea. Additional authors for this research include Chris Wasden and Doug Hyun Han.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1016/j.cmpb.2021.106319. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

The publisher of the journal Computer Methods and Programs in Biomedicine can be contacted at: Elsevier Ireland Ltd, Elsevier House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000, Ireland.

(Our reports deliver fact-based news of research and discoveries from around the world.)